Lumito AB (NGM:LUMITO) 5-Year Yield-on-Cost %: 0.00 (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:LUMITO Lumito AB NGM:LUMITO
16 GF Score
Price kr1.45
! 2 Warning Signs
View Full Analysis

What is Lumito AB 5-Year Yield-on-Cost %?

Lumito AB NGM:LUMITO -6.10% 16 5-Year Yield-on-Cost % is 0.00 as of Sep. 05, 2026. GuruFocus rates NGM:LUMITO with a GF Score™ of 16/100. The stock has 2 warning signs investors should review. Among 60 Medical Diagnostics & Research companies, Lumito AB ranks worse than 1666665% on this metric.

Lumito AB's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for Lumito AB's 5-Year Yield-on-Cost % or its related term are showing as below:



NGM:LUMITO's 5-Year Yield-on-Cost % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.485
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Lumito AB  (NGM:LUMITO) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Lumito AB 5-Year Yield-on-Cost % Related Terms


NGM:LUMITO vs TMO, DHR, NTRA: 5-Year Yield-on-Cost % Comparison

For the Diagnostics & Research subindustry, Lumito AB's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumito AB 5-Year Yield-on-Cost % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumito AB's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Lumito AB's 5-Year Yield-on-Cost % falls into.


NGM:LUMITO
16GF Score
Lumito AB NGM:LUMITO
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lumito AB 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Lumito AB is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Lumito AB (NGM:LUMITO) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Lumito AB and its competitors. According to the industry distribution chart, Lumito AB ranks #999999 out of 60 companies in the Medical Diagnostics & Research industry.
Is Lumito AB's 5-Year Yield-on-Cost % too high?
Lumito AB's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Lumito AB ranks #999999 out of 60 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Lumito AB has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Lumito AB's 5-Year Yield-on-Cost % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Lumito AB ranks #999999 out of 60 companies for 5-Year Yield-on-Cost %. This places Lumito AB in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Diagnostics & Research company?
The median 5-Year Yield-on-Cost % among Medical Diagnostics & Research companies is 2.49, based on 60 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Lumito AB and its competitors. For the Medical Diagnostics & Research industry, the median 5-Year Yield-on-Cost % is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lumito AB's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lumito AB stock overvalued right now?
Lumito AB (NGM:LUMITO) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Lumito AB's overall GF Score™ is 16/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Lumito AB (NGM:LUMITO), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lumito AB Business Description

Address Scheelevagen 19, Lund, SWE, 223 63
Lumito AB is a Swedish company that specializes in the medical research and development of imaging technology for use in digital pathology. It has developed the next-generation tissue analysis system, based on upconverting nanoparticles (UCNPs). Lumito SCIZYS is a cutting-edge, high-sensitivity system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company holds a broad patent portfolio of three patent families. Lumito's solution enables quantitative and objective assessment of tissue samples, addressing a multitude of challenges in drug development and academic research.
16GF Score

Get the complete analysis for NGM:LUMITO

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.45
Price